Cellectar Biosciences (NV40.MU) Q2 2026 Earnings

12MayConfirmed
Q1 2026
Next
-1.61
-0.89
-0.16
0.56

Details

Expected EPS
-1.60864015
Actual EPS
N/A
Surprise EPS
1.61
Surprise Percent
+100%

Description

Cellectar Biosciences (NV40.MU) will report earnings of for Q2 2026 on May 12, 2026.

0 Comments

Share your thoughts